Skip to main content

Advertisement

ADVERTISEMENT

News

White House Drug Policy Office Announces 15-State Heroin Response Strategy

Washington, D.C. – Today, Michael Botticelli, Director of National Drug Control Policy, announced $2.5 million to fund the Heroin Response Strategy, an unprecedented partnership among five regional HIDTA programs—Appalachia, New England, Philadelphia/Camden, New York/New Jersey, and Washington/Baltimore—to address the severe heroin threat facing those communities through public health-public safety partnerships across 15 states.

The Heroin Response Strategy will foster a collaborative network of public health-public safety partnerships to address the heroin/opioid epidemic from multiple perspectives. The Strategy will enhance the efficacy and efficiency of the criminal intelligence process in support of cooperative law enforcement operations. The five HIDTAs will create a 15-state network of experienced, connected law enforcement contacts and leverage these connections and information-gathering capabilities with a strong, complementary, analytical capacity.

The five HIDTAs will select two centrally located Regional Coordinators, one with a public health focus and the other with a public safety focus, who will manage and oversee implementation and operation of the Heroin Response Teams. The Public Health Coordinator will oversee regional reporting of fatal and non-fatal overdose information and issuing of relevant alerts regarding dangerous batches of heroin and other heroin-related threats to health authorities. This will mobilize a rapid public health response to distribute naloxone or expand resources in the affected areas, helping to mitigate the number of overdoses and prevent deaths. The Public Safety Coordinator will oversee execution of public safety goals by ensuring case support is provided where needed and intelligence is being disseminated to relevant law enforcement authorities to enable disruption of the heroin supply.

A heroin and prescription opioid training curriculum will be developed and used to prepare rural and municipal officers and first responders who are inexperienced responding to heroin and prescription opioid-related incidents. To assist communities in coping with this escalating problem, the five HIDTAs will developEducation & Training strategies that will increase awareness of heroin and opiate addiction, create linkages to available prevention and treatment resources in the respective regions, and enable first-responders to know how to report all pertinent lead information developed from seizures and overdose responses.

The Heroin Response Strategy builds upon the successes of the 2014 symposium hosted by the Washington/Baltimore HIDTA.  Each year, the five HIDTAs will host two, two-day State of the Region symposia at a jointly nominated HIDTA.  These symposia will build additional structure within each respective HIDTA region for the attendees to maintain regular contact and continue their public health-public safety partnerships between symposia. The aim will be to facilitate collaboration between public health and public safety partners within and across jurisdictions, sharing best practices, innovative pilots, and identifying new opportunities to leverage resources.

Background on the Administration’s National Drug Policy

The Obama Administration’s drug policy treats the national drug challenge as both a public health and public safety issue.  This approach is built upon the latest scientific research demonstrating that addiction is a chronic disease of the brain that can be successfully prevented and treated, and from which one can recover. The Administration has directed Federal agencies to expand community-based efforts to prevent drug use before it begins, empower healthcare workers to intervene early at the first signs of a substance use disorder, expand access to treatment for those who need it, support the millions of Americans in recovery, and pursue “smart on crime” approaches to drug enforcement.

For more information about the White House Office of National Drug Control Policy, visit www.whitehouse.gov/ondcp.

 

Advertisement

Advertisement

Advertisement